Previous 10 | Next 10 |
PacBio Announces Second Quarter 2022 Financial Results PR Newswire MENLO PARK, Calif. , Aug. 3, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022 . Second quarter results...
Pacific Biosciences has taken a punishment on the chart in FY22, having compressed down more than 86% in 12 months. PACB has de-rated as investors shift focus away from top-line growth stories and move onto bottom-line fundamentals. In that vein, PACB falls behind and valuations a...
Pacific Biosciences of California "PacBio" is a prime candidate for the "Bio Boom" Portfolio in my Compounding Healthcare Seeking Alpha Marketplace Service. I discuss how PACB meets the criteria. PacBio’s HiFi and SMRT sequencing technology continues to fuel growth. The company...
PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer PR Newswire MENLO PARK, Calif. , July 21, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solu...
PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022 PR Newswire MENLO PARK, Calif. , July 18, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 202...
ARK Invest’s 13F portfolio value decreased from $23.96B to $16.91B this quarter. Coinbase Global, Roku, Shopify, and Ginkgo Bioworks were increased while decreasing Spotify, Ionis Pharma, Vertex Pharma, and Sea Limited. The top three positions are Tesla, Zoom Video, and Rok...
Baker Brothers’ 13F portfolio value decreased from $20.55B to $17.40B this quarter. Horizon Therapeutics was increased while decreasing Legend Biotech. The top three positions are Seagen, Incyte Corporation, and BeiGene, and they add up to almost 68% of the portfolio. ...
China is cutting its quarantine time for international travelers to 10 days, which is lending support to sectors like casino stocks. Morgan Stanley just published its Global Exposure Guide, which tracks revenue and cost exposure by region. "While China is a very important source of revenue fo...
CAMBRIDGE, United Kingdom, June 14, 2022 (GLOBE NEWSWIRE) -- Cambridge Epigenetix (CEGX), a life sciences tools and technology company which is revolutionizing genome sequencing, today announced the appointment of Peter J. Fromen as Chief Executive Officer effective July 18, 2022. Gail Marc...
Gainers: O2Micro International Limited (OIIM) +20%. Fluence Energy (FLNC) +7%. Allarity Therapeutics (ALLR) +7%. SIGA Technologies (SIGA) +6%. Blackbaud (BLKB) +5%. Losers: Redbox Entertainment (RDBX) -10%. Pacific Biosciences of California (PACB) -6%. Jamf Holding (JAMF...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, se...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...